Back
Baxter International Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
47
BAX
Baxter International
Last Price:
39.43
Seasonality Move:
3.63%
Sell
19
ALNY
Alnylam Pharmaceuticals
Last Price:
144.39
Seasonality Move:
13.15%
Sell
47
Baxter International (BAX)
is a Sell
Is Baxter International a Buy, Sell or Hold?
- The current Baxter International [BAX] share price is $39.65. The Score for BAX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- BAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $145.01. The Score for ALNY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BAX Stock Price Chart
What is Baxter International's stock price today?
-
The Baxter International share price today is $39.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BAX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $145.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
BAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.54 | Sell |
| Relative Strength Index (14 RSI): | 34.35 | Sell |
| Chaikin Money Flow: | 1386398 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.68 - 42.92) | Sell |
| Bollinger Bands (100): | (37.85 - 42.13) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.85 | Sell |
| Relative Strength Index (14 RSI): | 36.49 | Sell |
| Chaikin Money Flow: | -95117 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (146.99 - 153.21) | Sell |
| Bollinger Bands (100): | (150.52 - 184.18) | Sell |
BAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.76 | Sell |
| 20-day SMA: | 41.8 | Sell |
| 50-day SMA: | 41.72 | Sell |
| 200-day SMA: | 39.69 | Sell |
| 8-day EMA: | 40.5 | Sell |
| 20-day EMA: | 41.35 | Sell |
| 50-day EMA: | 41.25 | Sell |
| 200-day EMA: | 40.98 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 149.25 | Sell |
| 20-day SMA: | 150.56 | Sell |
| 50-day SMA: | 152.9 | Sell |
| 200-day SMA: | 174.34 | Sell |
| 8-day EMA: | 148.14 | Sell |
| 20-day EMA: | 150.07 | Sell |
| 50-day EMA: | 155.18 | Sell |
| 200-day EMA: | 171.66 | Sell |
Baxter International Earnings Growth & BAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $0.33 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.42 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.51 per share, and an increase next year of $1.82 per share.
Baxter International Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||